Compound Detail
CHEMBL2022968
DUBERMATINIB 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL2022968 |
| Name | DUBERMATINIB |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | YUAALFPUEOYPNX-UHFFFAOYSA-N |
4
Targets
8
Activities
2
Assay Types
14
PK Parameters
20
Publications
5
Known Names
3
Indications
Molecular Properties
516.1
MW (Da)
3.61
ALogP
8
HBA
2
HBD
93.7
PSA (Ų)
0.47
QED
1
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Indications
Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Myeloid, Acute Neoplasms
Activity Summary
IC50 6 meas. best 8.52
EC50 2 meas. best 6.65
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Aurora kinase A CHEMBL4722 | IC50 | 8.52 | 8.52 | 3.0 | 1 |
| Aurora kinase B CHEMBL2185 | IC50 | 7.91 | 7.91 | 12.4 | 1 |
| Tyrosine-protein kinase receptor UFO CHEMBL4895 | IC50 | 7.82 | 7.6533 | 15.0 | 3 |
| PSN1 CHEMBL614241 | IC50 | 7.22 | 7.22 | 60.0 | 1 |
| Tyrosine-protein kinase receptor UFO CHEMBL4895 | EC50 | 6.65 | 6.585 | 222.0 | 2 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 158.0 | ng.hr.mL-1 | Rattus norvegicus |
| AUC | 187.0 | ng.hr.mL-1 | Rattus norvegicus |
| CL | 645.7 | mL.min-1.kg-1 | Homo sapiens |
| CL | 20.1 | mL.min-1.kg-1 | Homo sapiens |
| CL | 581.9 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 50.4 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 0.08283 | mL.min-1.kg-1 | Rattus norvegicus |
| Cmax | 90.69 | nM | Rattus norvegicus |
| Cmax | 174.01 | nM | Rattus norvegicus |
| F | 21.5 | % | Rattus norvegicus |
| T1/2 | 0.045 | hr | Homo sapiens |
| T1/2 | 0.07167 | hr | Rattus norvegicus |
| T1/2 | 2.94 | hr | Rattus norvegicus |
| T1/2 | 1.77 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL4689842 | HEK-293T | 345 |
| - | 10.6019/CHEMBL4689842 | Fibroblast | 344 |
| - | 10.6019/CHEMBL4689842 | U2OS | 344 |
| 36325401 | 10.1039/d2md00153e | ADMET | 14 |
| - | 10.6019/CHEMBL5724558 | Colon cancer organoid | 12 |
| - | 10.6019/CHEMBL5674860 | Colon cancer organoid | 12 |
| - | 10.6019/CHEMBL5724696 | U2OS | 8 |
| 22247788 | 10.1021/ml200198x | Tyrosine-protein kinase receptor UFO | 6 |
| - | 10.6019/CHEMBL5608141 | Colon cancer organoid | 6 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| 22247788 | 10.1021/ml200198x | Aurora kinase B | 3 |
| 22247788 | 10.1021/ml200198x | PSN1 | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 2 |
| 22247788 | 10.1021/ml200198x | Aurora kinase A | 2 |
| - | 10.21203/rs.3.rs-23951/v1 | SARS-CoV-2 | 1 |
| 22247788 | 10.1021/ml200198x | Tyrosine-protein kinase ABL1 | 1 |
| 22247788 | 10.1021/ml200198x | ALK tyrosine kinase receptor | 1 |
| - | 10.1021/acschembio.2c00877 | Colon organoid | 1 |
Data from ChEMBL 36 via Core Engine